Nonopioid treatments for chronic pain by unknown
CS263451 March 14, 2016
NONOPIOID TREATMENTS 
FOR CHRONIC PAIN 
PRINCIPLES OF CHRONIC PAIN TREATMENT
Patients with pain should receive treatment that provides the greatest benefit. Opioids are not the first-line therapy for 
chronic pain outside of active cancer treatment, palliative care, and end-of-life care. Evidence suggests that nonopioid 
treatments, including nonopioid medications and nonpharmacological therapies can provide relief to those suffering 
from chronic pain, and are safer. Effective approaches to chronic pain should: 
Use nonopioid therapies to the extent possible 
Identify and address co-existing mental health 
conditions (e.g., depression, anxiety, PTSD) 
Focus on functional goals and improvement, engaging 
patients actively in their pain management 
Use disease-specific treatments when available (e.g., 
triptans for migraines, gabapentin/pregabalin/duloxetine 
for neuropathic pain) 
Use first-line medication options preferentially 
Consider interventional therapies (e.g., 
corticosteroid injections) in patients who fail 
standard non-invasive therapies 
Use multimodal approaches, including 
interdisciplinary rehabilitation for patients who have 
failed standard treatments, have severe functional 
deficits, or psychosocial risk factors
NONOPIOID MEDICATIONS
Medication Magnitudeof benefits Harms Comments
Acetaminophen Small Hepatotoxic, particularly at higher doses First-line analgesic, probably less effective than NSAIDs
NSAIDs Small-moderate Cardiac, GI, renal First-line analgesic, COX-2 selective NSAIDs less GI toxicity
Gabapentin/pregabalin Small-moderate Sedation, dizziness, ataxia First-line agent for neuropathic pain; pregabalin approved for fibromyalgia




TCAs have anticholinergic 
and cardiac toxicities; 
SNRIs safer and better 
tolerated
First-line for neuropathic pain; TCAs and SNRIs for fibromyalgia, TCAs for 
headaches
Topical agents (lidocaine, 
capsaicin, NSAIDs) Small-moderate
Capsaicin initial flare/
burning, irritation of 
mucus membranes
Consider as alternative first-line, thought to be safer than systemic 
medications. Lidocaine for neuropathic pain, topical NSAIDs for localized 
osteoarthritis, topical capsaicin for musculoskeletal and neuropathic pain
LEARN MORE  |  www.cdc.gov/drugoverdose/prescribing/guideline.html
RECOMMENDED TREATMENTS FOR 
COMMON CHRONIC PAIN CONDITIONS 
LEARN MORE  |  www.cdc.gov/drugoverdose/prescribing/guideline.html
Low back pain
Self-care and education in all patients; advise 
patients to remain active and limit bedrest
Nonpharmacological treatments: Exercise, cognitive 
behavioral therapy, interdisciplinary rehabilitation 
Medications 
 • First line: acetaminophen, non-steroidal anti inflammatory
drugs (NSAIDs)






 • Antiseizure medications
 • Calcium channel blockers
 • Non-pharmacological treatments (Cognitive behavioral
therapy, relaxation, biofeedback, exercise therapy)
 • Avoid migraine triggers
Acute treatments 
 • Aspirin, acetaminophen, NSAIDs (may be combined with
caffeine)
 • Antinausea medication
 • Triptans-migraine-specific
Neuropathic pain
Medications: TCAs, SNRIs, gabapentin/pregabalin, 
topical lidocaine 
Osteoarthritis
Nonpharmacological treatments: Exercise, weight 
loss, patient education 
Medications 
 • First line: Acetamionphen, oral NSAIDs, topical NSAIDs
 • Second line: Intra-articular hyaluronic acid, capsaicin
(limited number of intra-articular glucocorticoid injections if
acetaminophen and NSAIDs insufficient)
Fibromyalgia
Patient education: Address diagnosis, treatment, 
and the patient’s role in treatment
Nonpharmacological treatments: Low-impact 
aerobic exercise (i.e. brisk walking, swimming, water 
aerobics, or bicycling), cognitive behavioral therapy, 
biofeedback, interdisciplinary rehabilitation 
Medications 
 • FDA-approved: Pregabalin, duloxetine, milnacipran
 • Other options: TCAs, gabapentin
